1. Home
  2. EVTV vs ALLR Comparison

EVTV vs ALLR Comparison

Compare EVTV & ALLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Envirotech Vehicles Inc.

EVTV

Envirotech Vehicles Inc.

HOLD

Current Price

$1.94

Market Cap

21.6M

ML Signal

HOLD

Logo Allarity Therapeutics Inc.

ALLR

Allarity Therapeutics Inc.

HOLD

Current Price

$1.14

Market Cap

25.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVTV
ALLR
Founded
2012
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Manufacturing
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
21.6M
25.6M
IPO Year
2014
2021

Fundamental Metrics

Financial Performance
Metric
EVTV
ALLR
Price
$1.94
$1.14
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$9.75
AVG Volume (30 Days)
435.1K
148.5K
Earning Date
04-13-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$5,939,008.00
$320,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
217.58
N/A
52 Week Low
$0.16
$0.77
52 Week High
$5.07
$2.35

Technical Indicators

Market Signals
Indicator
EVTV
ALLR
Relative Strength Index (RSI) 56.71 37.17
Support Level $1.61 $1.01
Resistance Level $2.26 $1.29
Average True Range (ATR) 0.18 0.10
MACD 0.05 -0.01
Stochastic Oscillator 82.29 28.42

Price Performance

Historical Comparison
EVTV
ALLR

About EVTV Envirotech Vehicles Inc.

Envirotech Vehicles Inc is a provider of purpose-built zero-emission electric vehicles focused on reducing the total cost of vehicle ownership and helping fleet operators unlock the benefits of green technology. It recognizes revenue from the sales of zero-emission electric vehicles and vehicle maintenance and inspection services. The Company serves commercial and last-mile fleets, school districts, public and private transportation service companies and colleges and universities to meet the increasing demand for light to heavy-duty electric vehicles.

About ALLR Allarity Therapeutics Inc.

Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States. It is focused on the clinical development of its lead program: Stenoparib, which is being co-developed with a drug specific DRP companion diagnostic.

Share on Social Networks: